Impact of different metabolic syndrome classifications on the metabolic syndrome prevalence in a young Middle Eastern population
Introduction
The metabolic syndrome (MetS) was first described by Reaven [1] in 1988 as a cluster of risk factors for diabetes and cardiovascular disease such as obesity, dyslipidemia, hypertension, and impaired fasting plasma glucose (FPG). Subsequently, several definitions for this entity have been proposed [2], [3], [4]. The 2 mainly retained definitions are those of the World Health Organization [2] and the National Cholesterol Education Program's (NCEP's) Adult Treatment Panel III (ATP-III) [4]. The ATP-III is more commonly used because its criteria are easily measurable because they do not include insulin resistance, which is a nonreproducible measurement [5].
Worldwide, the prevalence of the MetS significantly increases with age [6], [7], [8] and can vary in the same population depending on the used definition [9], [10]. This prevalence is also ethnic dependent [10], [11], [12], being much more prevalent in Hispanics compared with African Americans and Europeans [10]. In the Arab world, using the ATP-III panel criteria, the MetS prevalence was 24.3% in a population older than 40 years [13]. The prevalence of the MetS in populations younger than 30 years has been the subject of several publications [6], [7], [8], [14], [15], [16], [17]. Worldwide, this prevalence changes according to the study population and ranges from 2.9% [6] to 11.0% [7]. To our knowledge, no previous study looked at this prevalence in a Middle Eastern young population.
On the other hand, insulin resistance, which is not included in the ATP-III definition and which is commonly measured by the homeostatic model assessment (HOMA) index, predicts cardiovascular disease independently of the MetS [18].
The objective of this study is to assess the prevalence of the MetS according to the original and actualized ATP-III (ATP-IIIa) panel risk factors [4] in a representative sample of Lebanese students who are 18 to 30 years old. In addition, our study will define new cutoff values for the MetS parameters in our population and will look at the relation between MetS and HOMA index.
Section snippets
Participants
Participants were students recruited from the Saint Joseph University Medical Sciences Campus located in Beirut. This private university, the second biggest one in Lebanon, admits students from all parts of the country that has an overall population of 4 million inhabitants. To obtain a sample representative of the young Lebanese population based on probability, approximately 400 subjects were needed, taking into account an error of 2%. Students were recruited randomly using a computerized
Results
Three hundred eighty-one subjects were included in this cross-sectional study (201 men and 180 women). The population age ranges between 18 and 30 years, with a mean of 23.9. Baseline characteristics of the population (clinical and biological parameters) are shown in Table 1.
Discussion
Our results show that the prevalence of the MetS in a sample of the young Lebanese population is 5.25% using the ATP-III panel criteria. This prevalence is comparable with other published prevalences worldwide in the 18- to 30-year age range and using, similarly to our study, the ATP-III criteria. In the United States, in a 20- to 29-year-old population, this prevalence was 6.7% [14]. In European populations [7], [15], [16], [17], the prevalence ranges from 3% to 11%; it is the lowest in Italy
Acknowledgments
This work was fully supported by grants from the Conseil de la Recherche at Saint-Joseph University, Beirut, Lebanon, under the reference FM 122.
We are grateful to the members of the “Centre Universitaire de Santé Familiale et Communautaire” at Saint-Joseph University for their assistance.
References (44)
- et al.
The metabolic syndrome: prevalence in worldwide population
Endocrinol Metab Clin N Am
(2004) - et al.
Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome
J Thromb Haemost
(2007) - et al.
Metabolic syndrome components in African-Americans and European-American patients and its relation to coronary artery disease
Am J Cardiol
(2007) - et al.
Prevalence of the metabolic syndrome among Italian adults according to ATP III definition
Nutr Metab Cardiovasc Dis
(2005) - et al.
Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study
J Am Coll Cardiol
(2007) - et al.
Comparative evaluation of simple indices of insulin resistance
Metabolism
(2004) - et al.
The US National Cholesterol Education Program's Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population
Diabetes Res Clin Pract
(2005) - et al.
The metabolic syndrome—a new worldwide definition
Lancet
(2005) - et al.
High prevalence of the metabolic syndrome among Northern Jordanians
J Diabetes Complications
(2007) Banting lecture 1988. Role of insulin resistance in human disease
Diabetes
(1988)
Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus
Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)
Diabet Med
Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final report
Circulation
Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?
Diabetes Care
Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study
BMC Public Health
The prevalence of metabolic syndrome among young adults in Izmir, Turkey
Anadolu Kardiyol Derg
Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach
Arch Dis Child
Metabolic syndrome pandemic
Arterioscler Thromb Vasc Biol
The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria
Diabet Med
Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey
JAMA
Clustering of metabolic syndrome risk factors and arterial stiffness in young adults: the Northern Ireland Young Hearts Project
J Hypertens
The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study
Diabetes Obes Metab
Cited by (0)
This work was done at Saint-Joseph University, Beirut, Lebanon.
- 1
Rima Chedid and Marie-Hélène Gannagé-Yared are first coauthors in this article.